Skip to Content

Join the 'Cervical Cancer' group to help and get support from people like you.

Cervical Cancer News

Related terms: Cancer, Cervix

HPV Vaccine Safe for Adult Women: Study

Posted 4 days ago by Drugs.com

WEDNESDAY, Oct. 18, 2017 – Vaccines that ward off the cancer-linked human papillomavirus (HPV) are safe for adult women, according to a study of more than 3 million Scandinavians. The researchers, who used Danish and Swedish hospital data to track the incidence of 44 different illnesses over 10 years, found no "serious safety concerns" for women who'd gotten the HPV vaccine to reduce their odds for cervical cancer. The vast majority of cervical cancers are thought to be caused by infection with HPV. Diseases or conditions studied in the new analysis included epilepsy, paralysis, lupus, psoriasis, type 1 diabetes, rheumatoid arthritis, thyroid issues and Crohn's disease, among others. The study did find slightly higher odds for celiac disease among vaccinated women, but this was seen only in Denmark. The authors noted that celiac disease is "markedly underdiagnosed" in the Danish ... Read more

Related support groups: Cancer, Gardasil, Cervical Cancer, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Need Cancer Screening? Where You Work Matters

Posted 9 days ago by Drugs.com

FRIDAY, Oct. 13, 2017 – Waiters, contractors and other employees of America's small businesses are more likely to miss out on cancer screening, mostly because of a lack of insurance, new research shows. "Workers employed at smaller organizations had substantially lower breast, cervical and colorectal cancer screening rates" compared to people working at larger corporations or organizations, American Cancer Society (ACS) researchers reported. And poorer insurance coverage accounted for much of these differences, said the team led by ACS researcher Stacey Fedewa. One breast cancer specialist who reviewed the findings said the issue is an important one, because mammograms, colonoscopies and other screens can save lives – not to mention health care dollars. So it's crucial to "find ways to ensure that workers in smaller companies have access to health care," said Dr. Stephanie Bernik, ... Read more

Related support groups: Cancer, Breast Cancer, Colonoscopy, Colorectal Cancer, Breast Cancer - Adjuvant, Cervical Cancer, Breast Cancer, Prevention

Fewer Uninsured Cancer Patients After Medicaid Expansion

Posted 27 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 27, 2017 – States that expanded Medicaid under the Affordable Care Act halved the number of uninsured cancer patients, a new U.S. study finds. This matters because "uninsured cancer patients are more likely to go without needed care and treatment, such as radiation therapy or surgery to remove tumors," said study lead author Dr. Fumiko Chino. She is a radiation oncology resident at the Duke University School of Medicine. Chino and her colleagues analyzed the records of more than 197,000 cancer patients ages 18 to 64. All were newly diagnosed with cancer between 2011 and 2014 and received radiation as part of their treatment. The percentage of uninsured patients fell 52 percent on average in states that expanded Medicaid, while Medicaid enrollment rose from 15 to 18 percent. Medicaid is the publicly funded insurance program for the poor. In states that did not expand ... Read more

Related support groups: Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Skin Cancer, Cervical Cancer, Testicular Cancer, Solid Tumors

Where It's Legal, One-Quarter of Cancer Patients Use Medical Pot

Posted 25 Sep 2017 by Drugs.com

MONDAY, Sept. 25, 2017 – If you legalize medical marijuana, a sizable number of cancer patients will sign up, a new Washington state survey suggests. One-quarter of cancer patients in Washington use marijuana, researchers found. But the study also revealed it can be a challenge to get information about the drug from health care providers. "Cancer patients desire but are not receiving information from their cancer doctors about marijuana use during their treatment, so many of them are seeking information from alternate nonscientific sources," said study author Dr. Steven Pergam of Fred Hutchinson Cancer Research Center in Seattle. Marijuana is reported to ease symptoms related to cancer treatment, and U.S. cancer patients will have greater access to medical pot as acceptance and availability of marijuana increases nationwide, Pergam's team said. Currently, recreational marijuana is ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cannabis, Cervical Cancer

FDA Approves Mvasi (bevacizumab-awwb), a Biosimilar to Avastin

Posted 17 Sep 2017 by Drugs.com

September 14, 2017 – The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer. “Bringing new biosimilars to patients, especially for diseases where the cost of existing treatments can be high, is an important way to help spur competition that can lower healthcare costs and increase access to important therapies,” said FDA Commissioner Scott Gottlieb, M.D. “We’ll continue to work hard to ensure that biosimilar medications are brought to the market quickly, through a process that makes certain that these new medicines meet the FDA’s rigorous gold standard for safety and effectiveness.” Mvasi is approved for the treatment of adult patients with certain colorectal, lung, brain, kidney and cervical cancers ... Read more

Related support groups: Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Avastin, Cervical Cancer, Glioblastoma Multiforme, Bevacizumab, Mvasi

Mvasi Is First Biosimilar Drug Approved for Cancer

Posted 14 Sep 2017 by Drugs.com

THURSDAY, Sept. 14, 2017 – The first biosimilar drug to treat cancer has been approved by the U.S. Food and Drug Administration. Mvasi (bevacizumab-awwb) was found to be biosimilar to the anti-cancer drug Avastin, the FDA said Thursday in a news release. Avastin was approved in 2004. Biosimilar drugs are typically derived from living organisms and are approved after manufacturers demonstrate that the medications are "highly similar" to already approved drugs, the agency said. Mvasi is approved to treat certain cancers of the colon, lung, brain, kidney and cervix, the FDA said. "Bringing new biosimilars to patients, especially for diseases where the cost of existing treatments can be high, is an important way to help spur competition that can lower healthcare costs and increase access to important therapies," said FDA Commissioner Dr. Scott Gottlieb. He pledged new biosimilar drugs ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Avastin, Cervical Cancer, Bevacizumab, Mvasi

FDA OKs First 'Biosimilar' Drug to Fight Cancer

Posted 14 Sep 2017 by Drugs.com

THURSDAY, Sept. 14, 2017 – The first approval of a biosimilar drug to treat cancer was announced Thursday by the U.S. Food and Drug Administration. Mvasi (bevacizumab-awwb) was approved as a biosimilar to Avastin (bevacizumab) for the treatment of adults with certain colon, lung, brain, kidney and cervical cancers. A biosimilar is a biological product that is approved because it is highly similar to an already-approved biologic drug and has no significant differences in safety and effectiveness from the first product, the FDA explained. "Bringing new biosimilars to patients, especially for diseases where the cost of existing treatments can be high, is an important way to help spur competition that can lower health care costs and increase access to important therapies," FDA Commissioner Dr. Scott Gottlieb said in an agency news release. Mvasi is marketed by Amgen, Inc., headquartered in ... Read more

Related support groups: Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Brain Tumor, Avastin, Cervical Cancer, Bevacizumab, Mvasi

HPV Test Alone OK for Cervical Cancer Screening Over 30: Expert Panel

Posted 12 Sep 2017 by Drugs.com

TUESDAY, Sept. 12, 2017 – An influential U.S. panel of health experts is boosting support for the HPV test as a routine part of cervical cancer screening. The independent U.S. Preventive Services Task Force (USPSTF) – which issues closely heeded guidelines on a range of medical issues – says the test for the human papillomavirus (HPV) can be used once every five years for women aged 30 to 65, in lieu of the once every three-year Pap test. Prior guidelines had called for the use of both tests together. For younger women, aged 21 to 29, a Pap test once every three years is still the recommended screen, the panel said. Certain strains of sexually transmitted HPV are thought to cause the vast majority of cervical cancer cases. "One of the biggest differences between these guidelines and the former guidelines is that the new guidelines recommend against co-testing – HPV test and a Pap ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Cervical Cancer, Diagnosis and Investigation, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Gardasil 9

8 Ways College Women Can Protect Their Health

Posted 11 Sep 2017 by Drugs.com

MONDAY, Sept. 11, 2017 – The start of college means it's time for young women to take charge of their health. Dr. Aparna Sridhar, an assistant professor of obstetrics and gynecology at the University of California, Los Angeles, offers several tips in a university news release. Know your health status. Talk to your parents and your doctor to make sure you're up-to-date with health screenings, shots and prescriptions. Ask about the status of allergies and other health issues. Guard against HPV. Sridhar said college students should make sure they have been immunized for human papilloma virus (HPV), a sexually transmitted infection. "It can cause cervical cancer but can be prevented by the HPV vaccination and screening with pap smears," she said. Know how to get health care on campus. Find out the location of the closest health center that accepts your insurance. Keep track of menstrual ... Read more

Related support groups: Birth Control, Contraception, Plan B, Emergency Contraception, Mirena, Nexplanon, Depo-Provera, Allergic Reactions, Provera, NuvaRing, Sprintec, Urinary Tract Infection, Implanon, Allergies, Ortho Tri-Cyclen, Tri-Sprintec, Microgestin Fe 1/20, Yasmin, Plan B One-Step, Loestrin 24 Fe

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris Hansen, president of the American Cancer Society Cancer Action Network, said in a network news release. "Yet costs remain a challenge for those facing cancer. Our country and our lawmakers should come together to find bipartisan solutions that begin to address patient costs without sacrificing the quality of coverage," he urged. Researchers surveyed financial navigators at 11 hospitals in nine states. Financial navigators – typically trained social workers or nurses – help cancer patients ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Breast Cancer, Prostate Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Brain Tumor, Letrozole, Tarceva, Megestrol

Insured, But Still Barred From Top-Tier Cancer Centers

Posted 20 Jul 2017 by Drugs.com

THURSDAY, July 20, 2017 – Choosing a cheaper health plan could cost you access to cream-of-the-crop cancer doctors and facilities, a new study reports. Less-expensive "narrow network" health plans are much less likely to cover treatment by doctors at centers affiliated with the U.S. National Cancer Institute, said study lead author Laura Yasaitis. "We found that the narrower networks were more likely to systematically exclude NCI-affiliated physicians," said Yasaitis, a postdoctoral researcher with the University of Pennsylvania School of Medicine. "The oncologists they included in their networks were about half as likely to be NCI-affiliated as those they excluded." NCI-Designated Cancer Centers are the nation's top-flight facilities for cancer care, and studies have shown that patients treated at these centers tend to have better outcomes, Yasaitis said. Access to these centers is ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Cervical Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Gastric Cancer

Many Terminal Cancer Patients Remain in Denial

Posted 20 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should appropriately assess patients' readiness for prognostic information," said study leader Siew-Tzuh Tang, a professor at Chang Gung University School of Nursing in Taiwan. Doctors should respect patients' reluctance to confront their poor prognosis if they are not ready to know, "but sensitively coach them to cultivate their accurate prognostic awareness," Tang said in a journal news release. The study involved nearly 250 terminal cancer patients in Taiwan. They were questioned several times over their last ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Post Traumatic Stress Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Ovarian Cancer, Pancreatic Cancer, Skin Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Prostate Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Anastrozole, Votrient, Brain Tumor, Avastin

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, the clinical trials studied extended life by 3.34 million years, the study found. SWOG estimates the dollar return on investment from federal funding at $125 for each year of life gained. "A lot of people with cancer have lived longer because of the therapies tested in our publicly funded trials," study leader Joseph Unger said in a SWOG news release. He is an assistant member of the Fred Hutchinson Cancer Research Center's Cancer Prevention Program in Seattle. "At the same time, the cost of ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Accutane, Prostate Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Tretinoin, Fluorouracil, Lupron Depot, Femara, Lung Cancer, Gleevec, Rituxan, Isotretinoin, Colorectal Cancer

Reporting Symptoms Online to Docs Helps Cancer Patients Live Longer

Posted 4 Jun 2017 by Drugs.com

SUNDAY, June 4, 2017 – When people with advanced cancer report their symptoms to health care providers using an online program, they may live longer, a new study suggests. The benefit may come because the new online tool cuts any "lag time" between patients experiencing symptoms and their care team's response to those issues, the researchers said. "Patients receiving chemotherapy often have severe symptoms, but doctors and nurses are unaware of these symptoms up to half of the time," explained study author Dr. Ethan Basch, a professor of medicine at the University of North Carolina's Lineberger Comprehensive Cancer Center. Dr. Bruce Johnston, President-Elect of the American Society of Clinical Oncology (ASCO), said the new technology addresses a common problem in cancer care. "A lot of patients are reluctant to contact docs between visits – they may think, 'I don't feel too good, but ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Head and Neck Cancer

Page 1 2 3 4 5 6 7 8 9 10 Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, fluorouracil, Avastin, hydroxyurea, carboplatin, cisplatin, cyclophosphamide, bevacizumab, Hycamtin, view more... topotecan, Platinol, Mvasi, Paraplatin, Ifex, ifosfamide, Carboplatin Novaplus, Platinol-AQ